NHS National Framework for Transition products (Nilotinib and Ticagrelor)
NHS England North East and Yorkshire Health and JusticecontractFind a Tender ↗Ref ocds-h6vhtk-04ff90Procurement Act 2023SME suitablepending
Estimated value
—
Awarded value
£22.1m
Awarded 11 Jun 2025
Suppliers
8
4 SME
Lots
1
1 awarded
Published
11 Jul 2025
Other contracts from NHS England North East and Yorkshire Health and Justice· 10
Most recent notices published by the same contracting authority.
Other contracts awarded to ZYDUS PHARMACEUTICALS UK LTD· 9
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| NHS National Branded Interim - 1 June 2026 | contract | — | 22 May 2026 |
| NHS National Branded Interim - 1 June 2026 | contract | — | 16 Apr 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | contract | — | 26 Feb 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | contract | — | 14 Jan 2026 |
| NP49425 Generic and Biosimilar Transition Medicines | contract | — | 19 Dec 2025 |
| NHS National Framework for Generics Housekeeping | contract | — | 11 Nov 2025 |
| NHS National Framework for Transition products (Nilotinib and Ticagrelor) | contract | — | 20 Aug 2025 |
| Gastrointestinal, Endocrine, Nutrition & Blood Medicines | contract | — | 25 Jul 2025 |
| NHS National Framework for Transition products (Nilotinib and Ticagrelor) | contract | — | 11 Jul 2025 |